Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
CVS Health Corp
(NY:
CVS
)
69.75
+1.03 (+1.50%)
Official Closing Price
Updated: 4:10 PM EDT, Apr 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CVS Health Corp
< Previous
1
2
3
Next >
The Honest Company is Undergoing an Honestly Solid Turnaround
March 19, 2024
The Honest Company stock is up 30% after the company issued a bullish outlook for 2024 revenue and earnings, particularly in the second half of the year
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
AM Best Affirms Credit Ratings of Most of CVS Health Corporation’s Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna
March 13, 2024
From
AM Best
Via
Business Wire
Can UnitedHealth Group afford to keep Medicare Advantage plans?
February 19, 2024
UnitedHealth Group has, to date, been unaffected by the rising costs of Medicare Advantage; investors must decide if that shoe is yet to drop
Via
MarketBeat
CVS Corp. (NYSE: CVS) Making Surprising Moves in Tuesday Session
December 05, 2023
Via
Investor Brand Network
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
September 19, 2023
Via
Investor Brand Network
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
August 02, 2023
Via
Investor Brand Network
S&P 500 rockets to new highs as earnings beat estimates
February 09, 2024
The S&P 500 hits new highs as 10 of the 11 S&P sectors report positive Q4 earnings surprises. The tech and energy sectors are among the earnings leaders.
Via
MarketBeat
Topics
ETFs
Earnings
Stocks
Exposures
Financial
US Equities
Humana EPS shocker. Are Medicare Advantage plans in jeopardy?
January 30, 2024
Humana shares are falling after the health insurance carrier reported a bombshell when it cut its 2024 and 2025 earnings guidance
Via
MarketBeat
MarketBeat Week in Review – 1/15 - 1/19
January 20, 2024
The market continues to bounce back and forth as investors wait on news from the Federal Reserve later this month, but inflation may still be the bigger story
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Are CVS store closures prescription for better financial health?
January 17, 2024
CVS plans to close dozens of Target pharmacies starting in February. Amid retail pharmacy challenges, CVS is shifting toward the managed-care industry.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Walgreens Boots Alliance: Is it time to take this Dog for a walk?
January 04, 2024
Walgreens cut its dividend in half to right-size the payment and preserve cash flow; the stock still yields about 4% and trades at a deep value.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Quick list of bargain stocks to end the year
December 15, 2023
Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally
Via
MarketBeat
MarketBeat Week in Review – 12/4 - 12/8
December 09, 2023
Stocks finished in the green to close the week; investors believe the jobs report will allow the Fed to leave interest rates unchanged when they meet next week
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Is CVS stock ready for a rebound?
December 07, 2023
After consolidating from this year's selloff, for those of us on the sidelines, this is about as clear a low as you can expect to see.
Via
MarketBeat
Mega merger in the works? Humana, Cigna explore big deal
December 02, 2023
Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.
Via
MarketBeat
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
3 value stocks you shouldn't let go of this quarter
November 15, 2023
The market has created the perfect opportunity for you to have your cake and eat it too. These three value stocks will likely be portfolio residents soon
Via
MarketBeat
Topics
Bankruptcy
Exposures
Financial
Legal
High-yield, low-beta value plays for buy-and-hold investors
November 14, 2023
High-yield stocks that trade at a value and come with a lower-than-average beta can help mitigate portfolio volatility and boost returns over time.
Via
MarketBeat
Topics
Economy
Exposures
Economy
3 healthy dividend stocks for buy and hold investors
November 08, 2023
Blue chip healthcare stocks like health insurers are supported by secular tailwinds and pay reliable dividends with an outlook for health growth
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Walgreen's Fresh New Lows, Is The Dividend Worth The Ride?
October 16, 2023
Walgreens stock became a clear value play, offering an attractive dividend yield and tailwinds to position it as an industry leaders are two reasons to watch
Via
MarketBeat
Topics
Bonds
Economy
Exposures
Debt Markets
Economy
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
September 28, 2023
Health insurers UnitedHealth, Humana, and Elevance pay steady dividends, offering stability even as the industry faces headwinds regarding Medicaid coverage.
Via
MarketBeat
It's a Good Time To Buy High-Yield Dogs of the Dividend Kings
September 12, 2023
These Dividend Kings have been hammered for the last year but now offer value and high yield with a chance for a significant share price rebound.
Via
MarketBeat
MarketBeat Week in Review – 8/28 - 9/1
September 02, 2023
The markets ended the week with mixed results as stocks enter what is historically the toughest month of the year and next week volume should pick up
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?
August 29, 2023
These two high-potential healthcare names bring a rare opportunity for investors to gain some exposure to quality businesses trading at a discount to industry
Via
MarketBeat
CVS Corp. (NYSE: CVS) Near Top of Volume Charts in Thursday Trading
August 17, 2023
Via
Investor Brand Network
More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings
August 08, 2023
With newfound business momentum and consensus EPS that's been topped in five straight quarters, GDRX could deliver a report shareholders have been waiting for.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
Time Warp: Walgreens Stock Travels Back in Time to 2010
July 11, 2023
Integrated healthcare and pharmacy retailer Walgreens Boots Alliance Inc. (NYSE: WBA) stock fell 21.75% year-to-date (YTD). Learn more about Walgreens shares.
Via
MarketBeat
Exposures
COVID-19
Accolade: A Rising Personalized AI-Powered Healthcare Platform
July 11, 2023
Accolade Inc. (NASDAQ: ACCD) provides an artificial intelligence (AI)-powered healthcare platform. Learn more about Accolade Inc. stock.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Time to Ring the Register on DoorDash Stock?
July 10, 2023
Food delivery platform DoorDash Inc. (NASDAQ: DASH) shares have climbed 61% in 2023. While it's still trading well below its all-time high of $257.25, achieved
Via
MarketBeat
InvestorNewsBreaks – Cisco Systems Inc. (NASDAQ: CSCO) Featured in Yahoo! Finance Article
July 05, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.